COSYNTROPIN (cosyntropin) by Novartis is clinical pharmacology cosyntropin, like acth, binds specific receptors in the plasma membrane of adrenal cortical cells in the zona fasciculata. First approved in 2009.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Cosyntropin, like ACTH, binds specific receptors in the plasma membrane of adrenal cortical cells in the zona fasciculata. The hormone-receptor complex activates adenylate cyclase, which stimulates the production of cyclic AMP. This leads to the conversion of cholesterol to…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache
Worked on COSYNTROPIN at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo